Vanguard Group’s Acurx Pharmaceuticals ACXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.4K | Sell |
145,537
-383,812
| -73% | -$196K | ﹤0.01% | 4164 |
|
|
2025
Q1 | $206K | Hold |
529,349
| – | – | ﹤0.01% | 4071 |
|
|
2024
Q4 | $431K | Hold |
529,349
| – | – | ﹤0.01% | 3978 |
|
|
2024
Q3 | $1.01M | Buy |
529,349
+37,662
| +8% | +$71.6K | ﹤0.01% | 3773 |
|
|
2024
Q2 | $1.11M | Hold |
491,687
| – | – | ﹤0.01% | 3759 |
|
|
2024
Q1 | $1.2M | Buy |
491,687
+85,300
| +21% | +$209K | ﹤0.01% | 3747 |
|
|
2023
Q4 | $1.56M | Buy |
406,387
+285,143
| +235% | +$1.09M | ﹤0.01% | 3688 |
|
|
2023
Q3 | $182K | Buy |
121,244
+200
| +0.2% | +$300 | ﹤0.01% | 4268 |
|
|
2023
Q2 | $321K | Buy |
121,044
+31,559
| +35% | +$83.6K | ﹤0.01% | 4223 |
|
|
2023
Q1 | $310K | Buy |
+89,485
| New | +$310K | ﹤0.01% | 4240 |
|